It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.
Saved in:
| Title: | It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. |
|---|---|
| Authors: | Trommer J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Ullrich M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Reissig F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Brühlmann SA; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Nitt-Weber AK; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Novy Z; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.; Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czech Republic., Hajduova K; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic., Kurfurstova D; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic., Hendrychova R; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic., Bouchal J; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic., Petrik M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.; Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czech Republic.; Laboratory of Experimental Medicine, University Hospital, Olomouc, Czech Republic., Neuber C; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Sihver W; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Stadlbauer S; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Pietzsch J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany., Kreller M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Kopka K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307, Dresden, Germany., Mamat C; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany., Zarschler K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany. k.zarschler@hzdr.de. |
| Source: | EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2025 Jun 19; Vol. 10 (1), pp. 31. Date of Electronic Publication: 2025 Jun 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Open Country of Publication: England NLM ID: 101714628 Publication Model: Electronic Cited Medium: Internet ISSN: 2365-421X (Electronic) Linking ISSN: 2365421X NLM ISO Abbreviation: EJNMMI Radiopharm Chem Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40536585 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: It's a match: use of the radionuclide theranostic pair <superscript>133</superscript>La/<superscript>225</superscript>Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Trommer+J%22">Trommer J</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ullrich+M%22">Ullrich M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Reissig+F%22">Reissig F</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Brühlmann+SA%22">Brühlmann SA</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Nitt-Weber+AK%22">Nitt-Weber AK</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Novy+Z%22">Novy Z</searchLink>; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.; Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hajduova+K%22">Hajduova K</searchLink>; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kurfurstova+D%22">Kurfurstova D</searchLink>; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hendrychova+R%22">Hendrychova R</searchLink>; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Bouchal+J%22">Bouchal J</searchLink>; Institute of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Petrik+M%22">Petrik M</searchLink>; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.; Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czech Republic.; Laboratory of Experimental Medicine, University Hospital, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Neuber+C%22">Neuber C</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Sihver+W%22">Sihver W</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Stadlbauer+S%22">Stadlbauer S</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Pietzsch+J%22">Pietzsch J</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kreller+M%22">Kreller M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kopka+K%22">Kopka K</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Mamat+C%22">Mamat C</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Zarschler+K%22">Zarschler K</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany. k.zarschler@hzdr.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101714628%22">EJNMMI radiopharmacy and chemistry</searchLink> [EJNMMI Radiopharm Chem] 2025 Jun 19; Vol. 10 (1), pp. 31. <i>Date of Electronic Publication: </i>2025 Jun 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Open%22">Springer Open </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101714628 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2365-421X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222365421X%22">2365421X </searchLink><i>NLM ISO Abbreviation: </i>EJNMMI Radiopharm Chem <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40536585 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s41181-025-00354-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 31 Titles: – TitleFull: It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Trommer J – PersonEntity: Name: NameFull: Ullrich M – PersonEntity: Name: NameFull: Reissig F – PersonEntity: Name: NameFull: Brühlmann SA – PersonEntity: Name: NameFull: Nitt-Weber AK – PersonEntity: Name: NameFull: Novy Z – PersonEntity: Name: NameFull: Hajduova K – PersonEntity: Name: NameFull: Kurfurstova D – PersonEntity: Name: NameFull: Hendrychova R – PersonEntity: Name: NameFull: Bouchal J – PersonEntity: Name: NameFull: Petrik M – PersonEntity: Name: NameFull: Neuber C – PersonEntity: Name: NameFull: Sihver W – PersonEntity: Name: NameFull: Stadlbauer S – PersonEntity: Name: NameFull: Pietzsch J – PersonEntity: Name: NameFull: Kreller M – PersonEntity: Name: NameFull: Kopka K – PersonEntity: Name: NameFull: Mamat C – PersonEntity: Name: NameFull: Zarschler K IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 06 Text: 2025 Jun 19 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2365-421X Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: EJNMMI radiopharmacy and chemistry Type: main |
| ResultId | 1 |
